Scandinavian journal of gastroenterology · 2014
Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
van Gerven Nicole M F, Verwer Bart J, Witte Birgit I, van Erpecum Karel J, van Buuren Henk R, Maijers Ingrid, Visscher Arjan P, Verschuren Edwin C, van Hoek Bart, Coenraad Minneke J, Beuers Ulrich H W, de Man Robert A, Drenth Joost P H, den Ouden Jannie W, Verdonk Robert C, Koek Ger H, Brouwer Johannes T, Guichelaar Maureen M J, Vrolijk Jan Maarten, Mulder Chris J J, van Nieuwkerk Carin M J, Bouma Gerd, Dutch Autoimmune hepatitis STUDY group
Аннотация
BACKGROUND AND AIMS: Epidemiological data on autoimmune hepatitis (AIH) are scarce. In this study, we determined the clinical and epidemiological characteristics of AIH patients in the Netherlands (16.7 million inhabitants).
METHODS: Clinical characteristics were collected from 1313 AIH patients (78% females) from 31 centers, including all eight academic centers in the Netherlands. Additional data on ethnicity, family history and symptoms were obtained by the use of a questionnaire.
RESULTS: The prevalence of AIH was 18.3 (95% confidential interval [CI]: 17.3-19.4) per 100,000 with an annual incidence of 1.1 (95% CI: 0.5-2) in adults. An incidence peak was found in middle-aged women. At diagnosis, 56% of patients had fibrosis and 12% cirrhosis in liver biopsy. Overall, 1% of patients developed HCC and 3% of patients underwent liver transplantation. Overlap with primary biliary cirrhosis and primary sclerosing cholangitis was found in 9% and 6%, respectively. The clinical course did not differ between Caucasian and non-Caucasian patients. Other autoimmune diseases were found in 26% of patients. Half of the patients reported persistent AIH-related symptoms despite treatment with a median treatment period of 8 years (range 1-44 years). Familial occurrence was reported in three cases.
CONCLUSION: This is the largest epidemiological study of AIH in a geographically defined region and demonstrates that the prevalence of AIH in the Netherlands is uncommon. Although familial occurrence of AIH is extremely rare, our twin data may point towards a genetic predisposition. The high percentage of patients with cirrhosis or fibrosis at diagnosis urges the need of more awareness for AIH.
METHODS: Clinical characteristics were collected from 1313 AIH patients (78% females) from 31 centers, including all eight academic centers in the Netherlands. Additional data on ethnicity, family history and symptoms were obtained by the use of a questionnaire.
RESULTS: The prevalence of AIH was 18.3 (95% confidential interval [CI]: 17.3-19.4) per 100,000 with an annual incidence of 1.1 (95% CI: 0.5-2) in adults. An incidence peak was found in middle-aged women. At diagnosis, 56% of patients had fibrosis and 12% cirrhosis in liver biopsy. Overall, 1% of patients developed HCC and 3% of patients underwent liver transplantation. Overlap with primary biliary cirrhosis and primary sclerosing cholangitis was found in 9% and 6%, respectively. The clinical course did not differ between Caucasian and non-Caucasian patients. Other autoimmune diseases were found in 26% of patients. Half of the patients reported persistent AIH-related symptoms despite treatment with a median treatment period of 8 years (range 1-44 years). Familial occurrence was reported in three cases.
CONCLUSION: This is the largest epidemiological study of AIH in a geographically defined region and demonstrates that the prevalence of AIH in the Netherlands is uncommon. Although familial occurrence of AIH is extremely rare, our twin data may point towards a genetic predisposition. The high percentage of patients with cirrhosis or fibrosis at diagnosis urges the need of more awareness for AIH.
Предметные рубрики MeSH
AdolescentAdultAge FactorsAgedAged, 80 and overAlanine TransaminaseAlkaline PhosphataseAnti-Inflammatory AgentsAntibodies, AntinuclearAsian PeopleBlack PeopleCarcinoma, HepatocellularChildChild, PreschoolFatigueFemaleHepatitis, AutoimmuneHumansImmunoglobulin GImmunosuppressive AgentsIncidenceJaundiceLiver CirrhosisLiver NeoplasmsMaleMiddle AgedNetherlandsPrevalenceRetrospective StudiesSex FactorsSouth AmericaSurveys and QuestionnairesWhite PeopleYoung Adult